Highlights GlucoTrack, Inc.

Equities

GCTK

US45824Q6061

Market Closed - Nasdaq Other stock markets 04:30:00 2024-07-12 pm EDT			5-day change	1st Jan Change
1.67 ^USD	+0.60%		-4.02%	+27.72%

Jul. 01	GlucoTrack, Inc. announced that it has received $0.1 million in funding	CI
Jun. 20	Glucotrack Announces the Appointment of Andy Balo to Board of Directors	CI

Highlights

Glucotrack Reports Successful Completion of First Reported Long-Term Preclinical Study of Its Epidural Glucose Monitoring Sensor	Jun. 13	CI
Glucotrack, Inc Announces 90-Day Preclinical Study Results That Demonstrate Sustained Accuracy of Its Implantable Continuous Blood Glucose Monitor	Jun. 05	CI
Glucotrack?s Epidural Glucose Monitoring Sensor Demonstrates Successful 30-Day Safety & Performance in Long-Term Preclinical Study	May. 16	CI
GlucoTrack, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	May. 15	CI
Glucotrack Expanding Glucose Monitoring Technology to Epidural Space	Apr. 16	MT
GlucoTrack, Inc. Announces Expansion of its Continues Glucose Monitoring Technology to Epidural Glucose Monitoring	Apr. 16	CI
Glucotrack Announces Increased Sensor Longevity for Its Implantable Continuous Blood Glucose Monitor	Apr. 02	CI
GlucoTrack, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	Mar. 28	CI
GlucoTrack, Inc. Announces Early Accuracy Data for its Implantable Continuous Glucose Monitor	Jan. 02	CI
GlucoTrack, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	Nov. 14	CI
GlucoTrack, Inc. Announces Executive Changes	23-10-12	CI
GlucoTrack, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	23-08-14	CI
Glucotrack, Inc. Announces Positive Data from Feasibility Study for Implantable Continuous Glucose Monitor	23-07-25	CI
GlucoTrack, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023	23-05-12	CI
GlucoTrack, Inc. Reports Earnings Results for the Full Year Ended December 31, 2022	23-03-31	CI
GlucoTrack, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022	22-11-14	CI
Glucotrack to Begin Research & Development of Novel Continuous Glucose Monitoring System	22-10-10	CI
GlucoTrack, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022	22-08-15	CI
GlucoTrack, Inc. Provides Development Update on its Gen 2 Non-Invasive Glucose Monitor	22-06-22	CI
GlucoTrack, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2022	22-05-16	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Highlights GlucoTrack, Inc.

Equities

GCTK

US45824Q6061

Highlights

Filters